Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2009
08/19/2009CN101511800A Triazolyl phenyl benzenesulfonamides
08/19/2009CN101511799A Cyclic amine compound
08/19/2009CN101511798A [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors
08/19/2009CN101511797A Benzimidazole modulators of VR1
08/19/2009CN101511795A 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
08/19/2009CN101511789A 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists
08/19/2009CN101511787A Substituted N-phenylmethyl -5-oxo-proline-2-amides as P2X7-receptor antagonists and their methods of use
08/19/2009CN101511429A Indulines derivatives and gpr119 agonists
08/19/2009CN101508692A Anthranilamides, process for the production thereof, and pest controllers containing the same
08/19/2009CN100528878C Tetrahydroquinoline derivatives and a process for preparing the same
08/19/2009CN100528866C Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
08/19/2009CN100528864C N-substituted-2-oxodihydropyridine derivative
08/19/2009CN100528863C Method for manufacture of sertindole
08/19/2009CN100528862C Ortho-substituted aryl amides for controlling invertebrate pests
08/19/2009CN100528846C Amine compounds and use thereof
08/19/2009CN100528834C Pharmaceutical compounds
08/19/2009CN100528821C Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
08/19/2009CN100528157C Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered oral
08/19/2009CN100528154C Malonyl-COA decarboxylase inhibitors useful as metabolic modulators
08/18/2009US7576245 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups; increasing the fluorous nature of an organic compound; 4-(1H,1H,2H,2H-Perfluorodecyl)benzenesulfonamide; N-[4-(1H,1H,2H,2H-perfluorodecyl)benzyloxycarbonyloxy]succinimide
08/18/2009US7576221 Substituted imidazole derivatives
08/18/2009US7576219 Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
08/18/2009US7576218 1-[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carbonitrile; -[2-(4-chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-4-(4-chloro-phenyl)-piperidine-4-carboxylic acid methyl ester; deposited on a stent or stent-graft device
08/18/2009US7576215 Anticholesterol agents; antidiabetic agents; cardiovascular disorders ; antiarthritic agents
08/18/2009US7576209 Breast, prostate and ovarian cancer; such as 1-[4-(9-phenyl-3-pyrimidin-2-yl[1,2,4]triazolo[3,4-f]-1,6-naphthyridin-8-yl)phenyl]cyclobutanamine; serine/threonine kinase (Akt) suppression
08/18/2009US7576207 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
08/18/2009US7576203 2-hydroxyacetylaminopyridine compound as chemical intermediate for producing cyclic diamine derivative such as 2-[4-[2-(benzimidazol-2-ylthio)ethyl]piperazin-1-yl]-N-[2,4-bis(methylthio)-6-methylpyridin-3-yl]acetamide; Acyl-coenzyme A cholesterol acyltransferase (ACAT) inhibitor
08/18/2009US7576198 A hydroxy compound containing substituted orpyridine, pyrazine, pyrimidine, oxazole, thiadiazole, quinoline, isoquinoline etc. as anti HIV agent, for treating AIDS
08/18/2009US7576114 6-(4-Bromo-2-chloro-phenylamino)-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; anticarcinogenic, antiproliferative, and antiinflammatory agents; mitogen-activated protein kinase inhibitors
08/18/2009US7576107 1-(2,6-dichloro-4-trifluoromethylphenyl)-3-cyano-5-(2-methoxyethylamino)4-trifluoromethylsulfonylpyrazole; insecticides; widen the spectrum of the pesticides; control of parasites in animals
08/18/2009US7576106 2-(4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-1-[4-(4-fluorobenzyl),4-hydroxypiperidin-1-yl]ethanone; potent chemokine receptor antagonists; antiinflammatory agents; immunotherapy; rheumatic diseases; antiarthritic agents; transplant rejection; multiple sclerosis
08/18/2009US7576105 Benzyl substituted (piperidin-4-yl)aminobenzamido derivatives
08/18/2009US7576104 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases
08/18/2009US7576100 Muscarinic agonists
08/18/2009US7576098 4-((3-Ethoxy-4-isopropoxyphenyl)(1H-imidazol-2-yl)methylamino)benzamidine; serine protease enzyme inhibiters; anticoagulants; kallikrein inhibitors; antithrombins; antiinflammatory agents; angina pectoris; myocardium infarction; antiischemic agents; bioavailability; side effect reductioncost efficiency
08/18/2009US7576097 Crystalline form of maraviroc
08/18/2009US7576089 CCR2 or CCR5 receptor antagonists; atherosclerosis, restenosis, lupus, organ transplant rejection and rheumatoid arthritis, cancer, multiple sclerosis, HIV infection; e.g. N-(2-((3S)-3-[(4-Hydroxy-4-phenylcyclohexyl)amino]pyrrolidin-1-yl)-2-oxoethyl)-3-(trifluoromethyl)benzamide
08/18/2009US7576087 3-(Phenylsulfonyl)-7-piperazin-1-yl-1H-pyrazolo[4,3-b]pyridine; 5-HT receptor subtype 5HT6; selective serotonin receptor antagonist; cognition actiators; alzheimer's disease; attention deficit disorder; antidepressant; antiepileptic agent; anxiolytic agents; obsessive compulsive disorder; Parkinson's
08/18/2009US7576086 N1-benzyl-N4-(phenylpropane-2-yl-3-ol)piperazine; triple action on hydroxytryptamine (5-HT), noradrenalin (NA)and dopamine(DA); on brain synapses; cytochrome P-450 monooxygenase enzyme system antagonists; enzyme inhibitors; side effect reduction
08/18/2009US7576082 rac-6-Chloro-3-(3-chloro-benzyl)-3-(1-methyl-1H-pyrazol-4-yl)-1,3-dihydro-indol-2-one; murine double minute (MDM2 ) oncogene inhibitor; feedback control loop of p53 mutant cells; inhibit the interaction between p53 and MDM2 proteins
08/18/2009US7576079 Viral polymerase inhibitors
08/18/2009US7576078 Tetrahydroquinoline analogues as muscarinic agonists
08/18/2009US7576076 1-Methyl,2,6-dioxo,4-(4-(ethyloxycarbony)piperazin-1-yl-),5-(3-trifluoromethylphenyl)methyl-)-1,2,3,6-tetrahydropyrimidine; antagonist, antagonism; psychoses; antidepressants; schizophrenia; psychological disorders; Alzheimer's disease; neurodegenerative diseases;drug abuse, drug dependence (cocaine)
08/18/2009US7576074 Receptor-type kinase modulators and methods of use
08/18/2009US7576072 Heterocyclic inhibitors of MEK and methods of use thereof
08/18/2009US7576063 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole
08/18/2009CA2549479C Substituted arylpyrazoles as parasiticidal agents
08/18/2009CA2427831C Cyclization process step in the making of quinolones and naphthyridines
08/18/2009CA2393568C Diarylmethylpiperazines
08/18/2009CA2392030C Urea compounds having muscarinic receptor antagonist activity
08/18/2009CA2392028C Carbamate derivatives having muscarinic receptor antagonist activity
08/13/2009WO2009100294A2 Amide derivatives as positive allosteric modulators and methods of use thereof
08/13/2009WO2009099982A1 2-aminopyridine kinase inhibitors
08/13/2009WO2009099933A2 Preparation of esomeprazole magnesium and hydrates thereof
08/13/2009WO2009099929A1 Mesoionic pesticides
08/13/2009WO2009099177A1 Amino imidazole derivative
08/13/2009WO2009099172A1 Pharmaceutical product
08/13/2009WO2009099171A1 Pharmaceutical product
08/13/2009WO2009099133A1 Compound having carbazolyl group and use thereof
08/13/2009WO2009099086A1 3-substituted sulfonyl piperazine derivative
08/13/2009WO2009099080A1 Novel phenylpyrrole derivative
08/13/2009WO2009098901A1 3,8-diaminotetrahydroquinoline derivative
08/13/2009WO2009098576A1 Pyridinyl amides for the treatment of cns and metabolic disorders
08/13/2009WO2009098257A1 Composition for dyeing keratin fibres comprising at least one cationic diamino-n,n-dihydropyrazolone derivative
08/13/2009WO2009098144A1 Novel pyridinones and pyridazinones
08/13/2009WO2009098051A1 Aryl sulfonamides as effective analgesics
08/13/2009WO2009097998A1 Arylchalcogeno-arylalkyl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof
08/13/2009WO2009041705A9 5-membered heterocyclic compounds as proton pump inhibitors
08/13/2009WO2009030224A3 Novel quinazoline compounds and the use thereof for treating cancerous diseases
08/13/2009WO2009024341A3 Condensed anthran i lami de derivatives as insectisides
08/13/2009US20090204204 Drug/Drug Deliver Systems For The Prevention And Treatment Of Vascular Disease
08/13/2009US20090203916 Alzheimer's disease, senile dementia, Down syndrome or amyloidosis; 3E)-1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]piperidin-2-one; imidazolyl-functional compounds inhibit production of Amyloid beta 40 and Amyloid beta 42; low hygroscopicity; good solubility
08/13/2009US20090203915 Process for the preparation of solifenacin
08/13/2009US20090203911 Benzimidazole compound
08/13/2009US20090203907 Novel intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole
08/13/2009US20090203905 Chemical process
08/13/2009US20090203889 Bivalent linkers and conjugates thereof
08/13/2009US20090203747 Novel chemical compounds and the uses thereof as a medicine
08/13/2009US20090203743 Small molecule entry inhibitors
08/13/2009US20090203741 Crystals of benzoxadiazole derivative
08/13/2009US20090203736 Piperidine sulphonamide derivatives
08/13/2009US20090203714 Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors
08/13/2009US20090203711 Inhibitors of P38 Map Kinase
08/13/2009US20090203710 Novel piperidine derivative
08/13/2009US20090203702 INHIBITORS OF p38
08/13/2009US20090203699 Aminomethylpyridine derivatives, method for preparing same and therapeutic use thereof
08/13/2009US20090203697 Heterocyclic type cinnamide derivative
08/13/2009US20090203696 Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics
08/13/2009US20090203694 Inhibitors of undecaprenyl pyrophosphate synthase
08/13/2009US20090203684 Tyrosine kinase inhibitors
08/13/2009US20090203676 G-protein Coupled Receptor Agonists
08/13/2009US20090203674 Pyrimidine compound and pests controlling composition containing the same
08/13/2009US20090203666 Compounds and compositions as hedgehog pathway modulators
08/13/2009US20090203664 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6- diazabicyclo[3.2.0]heptane
08/13/2009US20090203657 Dual Pharmacophores - PDE4-Muscarinic Antagonistics
08/13/2009US20090202725 Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
08/13/2009US20090202476 Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide
08/13/2009US20090202449 Use of osteopontin in dental formulations
08/13/2009US20090199351 Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
08/13/2009CA2715143A1 Novel phenylpyrrole derivative